Bath & Body Works Q2 sales fall 2.1%; full-year guidance updated, buybacks raised
Bath & Body Works reported second quarter 2024 net sales of $1,526 million, down 2.1% from $1,559 million a year earlier, and adjusted earnings per diluted share of $0.37 versus $0.40. The company updated its full-year 2024 guidance and raised planned share repurchases to $400 million from $300 million, while reported earnings per share rose to $0.68 on one-time gains and a tax benefit.
Key points
- Q2 2024 net sales $1,526 million, down 2.1%; reported EPS $0.68 vs. $0.43, adjusted EPS $0.37 vs. $0.40
- Reported Q2 results include a $39 million pre-tax gain on Easton investment sales and a $44 million tax benefit
- Full-year 2024 adjusted EPS guidance $3.06 to $3.26, vs. $3.27 adjusted EPS in fiscal 2023; net sales guided to a decline of 4% to 2%
- Planned share repurchases for 2024 increased to $400 million from $300 million; Q3 2024 EPS guidance $0.41 to $0.47
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:01 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 28, 2024.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.